National guideline for the management of early syphilis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000993:Antitreponemal Agents / Q000627:therapeutic use*; D002601:Chancre / Q000175:diagnosis / Q000188:drug therapy; D004318:Doxycycline / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D010400:Penicillin G / Q000627:therapeutic use; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010402:Penicillin G Procaine / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy; D013587:Syphilis / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission; D013588:Syphilis Serodiagnosis; D014210:Treponema pallidum / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D000993:Antitreponemal Agents; C024657:benzathine benzylpenicillin, procaine benzylpenicillin, drug combination; D010402:Penicillin G Procaine; D004917:Erythromycin; D000658:Amoxicillin; D004318:Doxycycline; D010400:Penicillin G; D010401:Penicillin G Benzathine